Nieruchomości Polskie Towarzystwo Finansowesp. z o.o.

Realization of building projects related to erection of buildings

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-01-21
Share capital
1,986,000.00 PLN
Registered address
ul. Jazgarzewska 11, 00-730 Warszawa, Poland
Electronic delivery address
AE:PL-98000-54203-WHATW-23

Financials

Revenue history (in k)

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 77 days late).

  • 202519/06/2026
  • 202424/06/2025
  • 202317/06/2024
  • 202229/06/2023
  • 202130/09/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Sanctions and PEP lists

PersonList
Rafał Bolesław ZagórnyPoseł na Sejm Rzeczypospolitej Polskiej

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 12.38kMedianUSD 139.59kAverageUSD 1.43m
Net profit
This companyUSD 3.68kMedianUSD 274.12AverageUSD 142.64k
Operating costs
This companyUSD 3.42kMedianUSD 105.86kAverageUSD 1.16m
Assets
This companyUSD 566.70kMedianUSD 497.18kAverageUSD 3.93m

Authorized Representatives

Rafał Bolesław Zagórny – President of the Management Board

Manner of representation

In the case of a one-person management board, the President of the Management Board acts independently, or a commercial proxy acts independently; in the case of a multi-member management board, the President of the Management Board acts independently, two other members of the management board act jointly, or a member of the management board acts jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
19,860$536,466.77100%

Bank accounts

Registered as a VAT taxpayer on 2012-11-02.

  • mBank
    66 1140 1010 0000 5496 0800 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

FAQ

Last updated: 2026-10-07